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Background
Right ventricular (RV) function predicts prognosis in pul-
monary hypertension (PH) patients (pts) and right ventri-
cular (RV) failure. Prior studies evaluating of 3D RV
ejection fraction (EF) have yielded inconsistent prognostic
information. Here we explore the prognostic value of con-
trast enhanced Cardiac MRI (CMR) in PH (WHO group
1-5) pts.We hypothesize that CMR-Late Gadolinium
Enhancement (LGE), a marker for myocardial fibrosis
when present in RV or RV insertion points (RVIP), is a
predictor of adverse prognosis in PH pts and remains more
so when a quantitative analysis is incorporated.
Methods
A retrospective chart review of PH pts (n=42) who
underwent clinically indicated CMR were analyzed.
Demographic data: mean age 61 yrs; 26% male; WHO
group 1 (55%) group 2 (21%), group 3 (5%) group 4
(14%) group 5 (5%). RV volumetric data were indexed to
BSA, and along with RV LGE information (Binary and
Manual Quantitation: 5 SD threshold analysis) were cor-
related with MACE including hospitalization, death,
referral/need for lung transplantation and addition/
increase in inotropic therapy.
Results
LGE was positive (+) in 18 pts (43%) and negative (-) in
the remaining 24 pts (57%). The predominant MACE
events occur in the LGE+ group (78%). Specifically, in
LGE+ group, 7 pts (39%) had MACE while 11 pts (61%)
did not have MACE. In comparison, the LGE- group had
only 2 pts (8%) who had MACE and 22 pts (92%)who did
not have MACE, <0.03 for all). The results were similar
when WHO group 1 were sub analyzed. In WHO 1 sub-
group, 11 pts (48%) were LGE+ and 12 pts (52%) were
LGE-. In the LGE+ group 4 pts (36%) had MACE while 7
pts (64% did not. In the LGE- there were no MACE,
(<0.04). Fisher’s exact test was used for group compari-
sons. Univariate analysis revealed only RVESVI, RVEF,
RVEDVI and MRI LGE predicts MACE. However, via
multivariable logistic regression analysis only RVESVI
(OR: 1.1, 95%; CI 1.0-1.2) and MRI LGE (OR: 7.0,95%;CI
1.2-39.5) predict MACE.(c2=22.5,df=2, n=42, p<0.001). In
a subset of those +LGE pts who had none-zero fibrosis
after threshold quantitiation, no additive value was
demonstrable.
Conclusions
RV-LGE is >seven-fold stronger predictor of MACE than
standard CMR metrics in PHTN pts. LGE’s role as an
independent adverse prognosticator may define the patho-
physiologic hallmark in PH pts directly reflecting underly-
ing RV failure due to progressive myocardial fibrosis.
However, in limited fashion, quantitation appeared not to
add clincal value over visual assessment.
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